Merck KGaA





Real-time Estimate Tradegate 16:24:28 25/07/2024 BST 5-day change 1st Jan Change
155.35 EUR +0.23% Intraday chart for Merck KGaA +1.67% +7.63%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
Germany's Merck to Sell Surface Solutions Unit For $721 Million DJ
Merck KGaA to Sell Surface Solutions Unit for EUR665 Million MT
Merck KGaA to Divest Surface Solutions Segment for EUR665 Million MT
MERCK : xevinapant’s nasty scratch Alphavalue
MERCK KGAA : Gets a Buy rating from Barclays ZD
MERCK KGAA : Receives a Buy rating from Barclays ZD
Merck KGaA Secures Spot in German Supply Chain Digitalization Project MT
MERCK : Q2 cost absorption and the most recent cool development Alphavalue
German Stocks in Red as ECB Delivers Rate Hold MT
MERCK KGAA : Gets a Buy rating from Jefferies ZD
Merck KGaA to Buy French Semiconductor Metrology Group Unity-SC MT
JPMorgan rates Merck KGaA at 'Overweight' - Target 190 euros DP
Germany's Merck to Buy Unity-SC for at Least $170 Million DJ
MERCK KGAA : JP Morgan reaffirms its Buy rating ZD
Merck acquires French company Unity-SC for 155 million euros RE
MERCK KGAA : Receives a Buy rating from Jefferies ZD
Merck KGaA: share price down, analyst lowers target CF
MERCK KGAA : UBS lowers price target CF
UBS lowers target for Merck KGaA to 178 euros - 'Buy' DP
MERCK KGAA : UBS keeps its Buy rating ZD
Dawn Health and Merck Collaborate to Support Growth Disorders Care CI
Chemicals collective agreement: Bonus days for union members DP
Chemicals collective bargaining agreement: extra day for trade unionists DP
Chemical industry wage partners seek solution before the end of the peace period DP
German Stocks Fall Tuesday DJ
Chart Merck KGaA
More charts
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck: A lower starting point for future growth